Anna M. Rydzik
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Metabolomics and Mass Spectrometry Studies 6
- RNA and protein synthesis mechanisms 6
- RNA modifications and cancer 6
- Mitochondrial Function and Pathology 6
-
- Antibiotic Resistance in Bacteria 15
- Co-authors
- Christopher J. Schofield (28 shared papers)Timothy D. W. Claridge (21 shared papers)Jürgen Brem (17 shared papers)Jacek Jemielity (9 shared papers)Joanna Kowalska (7 shared papers)Edward Darżynkiewicz (7 shared papers)M.A. McDonough (11 shared papers)Sander S. van Berkel (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Angewandte Chemie International Edition (3 papers)Chemical Communications (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Organic & Biomolecular Chemistry (2 papers)
- Partner nations
- United KingdomPolandUnited States
In The Last Decade
Anna M. Rydzik
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 425
- Applied Microbiology and Biotechnology 48
- Pharmacology 212
- Cancer Research 137
- Clinical Biochemistry 61
Countries citing papers authored by Anna M. Rydzik
This map shows the geographic impact of Anna M. Rydzik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Rydzik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Rydzik more than expected).
Fields of papers citing papers by Anna M. Rydzik
This network shows the impact of papers produced by Anna M. Rydzik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Rydzik. The network helps show where Anna M. Rydzik may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna M. Rydzik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 101 | |
| 2 | 2013 | 99 | |
| 3 | 2016 | 85 | |
| 4 | 2014 | 66 | |
| 5 | 2010 | 62 | |
| 6 | 2015 | 57 | |
| 7 | 2014 | 56 | |
| 8 | 2009 | 51 | |
| 9 | 2011 | 49 | |
| 10 | 2012 | 49 | |
| 11 | 2015 | 37 | |
| 12 | 2014 | 33 | |
| 13 | 2015 | 32 | |
| 14 | 2017 | 28 | |
| 15 | 2011 | 28 | |
| 16 | 2018 | 27 | |
| 17 | 2012 | 24 | |
| 18 | 2015 | 23 | |
| 19 | 2013 | 21 | |
| 20 | 2014 | 21 |
About Anna M. Rydzik
Anna M. Rydzik is a scholar working on Molecular Biology, Molecular Medicine, Clinical Biochemistry, Pharmacology and Infectious Diseases, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Metabolism and Genetic Disorders (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Metabolomics and Mass Spectrometry Studies (6 papers), RNA and protein synthesis mechanisms (6 papers), RNA modifications and cancer (6 papers), Mitochondrial Function and Pathology (6 papers) and Tuberculosis Research and Epidemiology (5 papers). The work is most often cited by research in Molecular Medicine (425 citations), Applied Microbiology and Biotechnology (48 citations), Pharmacology (212 citations), Cancer Research (137 citations) and Clinical Biochemistry (61 citations). Anna M. Rydzik has collaborated with scholars based in United Kingdom, Poland and United States. Frequent co-authors include Christopher J. Schofield, Timothy D. W. Claridge, Jürgen Brem, Jacek Jemielity, Joanna Kowalska, Edward Darżynkiewicz, M.A. McDonough, Sander S. van Berkel, James Spencer and Ivanhoe K. H. Leung. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Angewandte Chemie International Edition, Chemical Communications, Bioorganic & Medicinal Chemistry Letters and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.